Westat, Inc.
Westat, Inc. is a prominent professional services firm that provides a wide range of research, technical assistance, and program support services to various federal agencies. Established in 1963 and headquartered in Rockville, Maryland, Westat specializes in survey research, data collection and analysis, program evaluation, and information technology solutions. The company has extensive experience working with government entities, particularly in areas such as public health, education, transportation, and social policy. Westat's federal contract and grant awards span numerous agencies, including the Department of Health and Human Services, Department of Education, National Science Foundation, and Department of Transportation, among others.
Through its federal contract awards, Westat has provided diverse services across multiple domains. For the National Cancer Institute, Westat has supported cancer clinical trials, offering services such as site study setup, protocol writing, and electronic patient-reported outcomes collection. The company has conducted national surveys for agencies like the National Highway Traffic Safety Administration, including occupant protection use surveys and booster seat usage studies. Westat has also provided data collection and analysis services for the Centers for Disease Control and Prevention, supporting programs such as the National Immunization Surveys. For the Food and Drug Administration, Westat has conducted studies on consumer perceptions of food labeling and medical device recalls. The company has also supported the Environmental Protection Agency with statistical analysis and technical support for various environmental health studies. These contracts demonstrate Westat's capabilities in large-scale data collection, analysis, and program evaluation across various public health and safety domains.
Westat's federal grant awards further showcase its expertise in research and evaluation services. The company has received grants from the National Institute of Justice to design and implement studies on interpersonal violence among young adults. For the National Institutes of Health, Westat has supported HIV/AIDS clinical trial networks and studies on maternal and child health. The company has also assisted the Bureau of Justice Statistics in conducting surveys on jails in Indian Country. Westat has collaborated with universities and research institutions on grants focused on topics such as sleep disparities, cognitive health, and substance abuse prevention. Additionally, the company has supported international health initiatives, such as population-based HIV impact assessment surveys in various countries. These grant-funded projects demonstrate Westat's ability to conduct complex, multi-year research studies and provide specialized data collection and analysis services in support of public health and social science research.
Westat holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, allowing for the issuance of task orders across a range of services. The company has a $320 million IDV with the National Cancer Institute for field and biospecimen support services, which includes study management, exposure assessment, and clinical support for cancer research. Westat also holds a $548 million IDV for the Cancer Trials Support Unit, providing broad-based support for cancer clinical trials. The Centers for Disease Control and Prevention awarded Westat a $310 million IDV for the National Immunization Surveys program, supporting vaccination coverage monitoring efforts. The company has a $175 million IDV with the National Institute of Child Health and Human Development for international and domestic pediatric HIV studies. Additionally, Westat holds IDVs with agencies such as the Substance Abuse and Mental Health Services Administration, the Administration for Community Living, and the Institute of Education Sciences, covering areas such as behavioral health research, aging and disability services, and education program evaluations. These IDVs demonstrate Westat's capacity to provide comprehensive, long-term support across various federal research and program evaluation initiatives.
NVUWAFWQ57S5 541720
Not listed 1600 Research Blvd, Rockville, MD 20850, USA
9/5/01 2/5/26 Essex Management LLC
Essex Management LLC is a privately held life sciences IT consulting and recruiting company. It provides a range of services to support federal agencies' biomedical informatics, data science, and IT needs.
Essex has received numerous federal contract awards as a prime contractor to deliver specialized services, including data management, analytics, reporting, project management, and subject matter expertise, to the Department of Health and Human Services' National Institutes of Health (NIH). Major contracts have supported various NIH institutes and programs, such as the National Cancer Institute, National Childhood Cancer Registry, and Childhood Cancer Data Initiative. Awards have been made under multiple indefinite-delivery/indefinite-quantity contracts and GSA Schedule vehicles for time-and-materials based work. Essex has also served as a subcontractor supporting contract efforts led by Leidos Biomedical Research Inc. and Standard Biotools Inc.
Essex holds several indefinite-delivery/indefinite-quantity contract vehicles to provide continued support to NIH, including a $1.7 billion National Cancer Institute IT Blanket Purchase Agreement, a $548 million Cancer Trials Support Unit contract, and a $350 million Biomedical Information Technology, Software Development contract. Task orders under these vehicles have delivered specialized services to meet critical NIH IT system, informatics, data analysis, and research support needs. Essex also holds a $500,000 GSA Schedule contract.
W43LZWHV2853 541511
Not listed 401 N Washington St #700, Rockville, MD 20850, USA
3/17/09 8/19/25 Technical Resources International, Inc.
Technical Resources International, Inc., doing business as Technical Resources Intl (TRI), is a minority-owned, woman-owned, Hispanic American-owned small business that specializes in providing comprehensive clinical research support services to federal health agencies. The company offers a wide range of services, including clinical trials execution, regulatory support, research operations, and specialized scientific services critical to advancing medical research and product development. TRI has extensive experience supporting biomedical research initiatives for various agencies, including the National Institutes of Health (NIH), Food and Drug Administration (FDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), and National Library of Medicine (NLM).
Over the past decade, TRI has been awarded over $1.1 billion in federal contracts as a prime contractor, demonstrating its significant role in supporting government health research initiatives. Notable awards include a $333.7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) for Clinical Research Operations and Management Support, a $317.1 million contract from ASPR for clinical trial planning and execution services, and a $171.4 million contract from the National Cancer Institute (NCI) for clinical trials sponsor and regulatory management support. TRI has also received multiple awards from other NIH institutes for services such as pharmacokinetic analysis, data coordination for clinical studies, and regulatory affairs support. These contracts typically involve complex clinical research services, often focusing on infectious diseases, cancer, and other critical health areas. While most awards are not set aside, TRI has received some contracts designated for small businesses. The company's work spans a wide range of activities, including clinical trial management, regulatory submissions, safety monitoring, data analysis, and scientific support for various research programs.
TRI holds several significant Indefinite Delivery Vehicles (IDVs) that enable rapid procurement of its services across federal health agencies. These include a $548 million multiple-award IDV with NCI for the Cancer Trials Support Unit, a $545.4 million single-award IDV with NIAID for comprehensive and rapid response to research programs, a $400 million single-award IDV with ASPR for clinical trials planning and execution, and a $364.5 million multiple-award IDV with NIAID for preclinical and translational vaccine development services. These IDVs cover a wide range of services, from clinical trial support and regulatory affairs to vaccine development and data management. Task orders issued under these vehicles have supported critical research initiatives in areas such as HIV, cancer, and emerging infectious diseases. For example, under the ASPR IDV, TRI has received task orders for clinical research support services, including project management, site selection and monitoring, specimen and product management, and regulatory affairs. The NIAID IDVs have facilitated rapid response to research needs, including support for clinical trials, manufacturing and controls, nonclinical animal studies, analytics, bioinformatics, and regulatory services.
FAA2LVENETH4 541715
Not listed 6500 Rock Spring Dr #650, Bethesda, MD 20817, USA
9/27/01 2/25/26 PPD Development LP
PPD Development LP is a global contract research organization (CRO) that provides comprehensive clinical trial and research support services to federal government agencies. As a subsidiary of Thermo Fisher Scientific, PPD offers expertise in areas such as regulatory affairs, clinical site monitoring, data management, and analytical testing to support the development of vaccines, therapeutics, diagnostics, and medical countermeasures. The company has been registered to receive federal awards since 2003 and has established itself as a key partner in advancing public health initiatives and medical research programs across multiple agencies and therapeutic areas.
Through prime federal contract awards, PPD Development LP has provided a wide range of services to agencies such as the National Institutes of Health (NIH), Department of Defense (DoD), and Department of Health and Human Services (HHS). These services include clinical site monitoring for the National Institute of Allergy and Infectious Diseases (NIAID), regulatory management support for NIAID's Regulatory Management Center, and comprehensive clinical trial management for COVID-19 studies. PPD has also conducted exploratory analyses for the National Human Genome Research Institute, developed U.S. Army blood products concepts of operations, and provided expanded access treatment protocols for HHS during the COVID-19 pandemic. The company has received multiple high-value contracts, including a $222 million contract from HHS for a Phase 2 clinical trial on acute respiratory distress syndrome and a $186 million contract from NIAID for clinical site monitoring services. Additionally, PPD has provided subcontract services to prime contractors such as General Dynamics Information Technology for various DoD and civilian agency projects.
PPD Development LP's involvement in federal grant awards primarily consists of subcontract work supporting prime grantees. The company has provided services for projects such as the DMPA XT study and Sayana Press initiatives through Family Health International, as well as clinical trial support for HIV-to-HIV deceased donor kidney transplantation research at Johns Hopkins University. PPD has also assisted the University of Pittsburgh with site responsibilities for pediatric clinical studies, including participant recruitment, data collection, and adverse event reporting. These grant-funded projects demonstrate PPD's capabilities in managing complex clinical trials, handling specialized laboratory services, and supporting research in various therapeutic areas.
The company holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies. Notable among these is a $545 million contract with NIAID for comprehensive and rapid response capabilities in research programs, supporting a range of clinical and non-clinical services. PPD also holds a $346 million multiple-award contract for NIAID's Early Phase Clinical Trial Units program, facilitating Phase 0 through Phase II trials for infectious diseases. Other IDVs include a $49.9 million contract with the National Institute on Drug Abuse for Blueprint MedTech clinical studies, a $24 million contract for regulatory affairs support in the same program, and a $548 million multiple-award contract with the National Cancer Institute for cancer trials support. These IDVs position PPD Development LP to provide a wide array of services across multiple agencies, including clinical trial management, regulatory affairs support, and specialized research and development activities.
ZANENSW6C665 541714
Not listed PPD Building, 929 N Front St, Wilmington, NC 28401, USA
5/6/03 1/6/26 EDJ Associates, Inc.
EDJ Associates, Inc. (EDJ) is a women-owned small business that offers professional services in conference and event management, online registration services, virtual events, grants management, peer review, and information/records management. EDJ has provided a range of services to federal agencies through prime and subcontract awards, including program management, logistical support, conference planning, training development, and other administrative services.
Through prime contract awards, EDJ has delivered services such as pharmaceutical management support, data management, project oversight, conference facilitation, workshop development, and webinar support to the National Institutes of Health, National Science Foundation, Department of Transportation, Department of the Interior, and other agencies. These services have supported medical research programs, transit administration, small business innovation partnerships, and environmental initiatives. Set-aside designations have included Woman-Owned Small Business, Small Disadvantaged Business, and Total Small Business set asides.
EDJ also holds several indefinite-delivery/indefinite-quantity contract vehicles to provide long-term administrative support, cancer trials support, and other services. These include the NIH Long-Term Administrative Support Contract III, the National Cancer Institute's Cancer Trials Support Unit, and a Blanket Purchase Agreement with the DOT Federal Transit Administration MAS schedule. Task orders under these vehicles have provided awareness training, data management, project oversight, logistical support for workshops, and other products and services to facilitate the program management and research missions of agencies like NIH, NCI, and FTA in a streamlined manner.
CAM5K35PN6D7 541611
Not listed 13873 Park Center Rd #381, Herndon, VA 20171, USA
10/29/02 5/17/25